132 related articles for article (PubMed ID: 38888058)
1. The medicinal chemistry of piperazines: A review.
Faizan M; Kumar R; Mazumder A; Salahuddin ; Kukreti N; Kumar A; Chaitanya MVNL
Chem Biol Drug Des; 2024 Jun; 103(6):e14537. PubMed ID: 38888058
[TBL] [Abstract][Full Text] [Related]
2. Synthetic Protocols, Structural Activity Relationship, and Biological Activity of Piperazine and its Derivatives.
Faizan M; Kumar R; Mazumder A; Salahuddin ; Kukreti N; Kumar A; Chaitanya M
Med Chem; 2024 Apr; ():. PubMed ID: 38685782
[TBL] [Abstract][Full Text] [Related]
3. Piperazine derivatives with central pharmacological activity used as therapeutic tools.
Brito AF; Moreira LKS; Menegatti R; Costa EA
Fundam Clin Pharmacol; 2019 Feb; 33(1):13-24. PubMed ID: 30151922
[TBL] [Abstract][Full Text] [Related]
4. Piperazine skeleton in the structural modification of natural products: a review.
Zhang RH; Guo HY; Deng H; Li J; Quan ZS
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1165-1197. PubMed ID: 34080510
[TBL] [Abstract][Full Text] [Related]
5. Piperazine derivatives for therapeutic use: a patent review (2010-present).
Rathi AK; Syed R; Shin HS; Patel RV
Expert Opin Ther Pat; 2016 Jul; 26(7):777-97. PubMed ID: 27177234
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of imidazoline derivatives active on glucose homeostasis in a rat model of type II diabetes. 2. Syntheses and biological activities of 1,4-dialkyl-, 1,4-dibenzyl, and 1-benzyl-4-alkyl-2-(4',5'-dihydro-1'H-imidazol-2'-yl)piperazines and isosteric analogues of imidazoline.
Le Bihan G; Rondu F; Pelé-Tounian A; Wang X; Lidy S; Touboul E; Lamouri A; Dive G; Huet J; Pfeiffer B; Renard P; Guardiola-Lemaître B; Manéchez D; Pénicaud L; Ktorza A; Godfroid JJ
J Med Chem; 1999 May; 42(9):1587-603. PubMed ID: 10229628
[TBL] [Abstract][Full Text] [Related]
7. Piperazine scaffold: A remarkable tool in generation of diverse pharmacological agents.
Shaquiquzzaman M; Verma G; Marella A; Akhter M; Akhtar W; Khan MF; Tasneem S; Alam MM
Eur J Med Chem; 2015 Sep; 102():487-529. PubMed ID: 26310894
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships of N-substituted piperazine amine reuptake inhibitors.
Fray MJ; Bish G; Fish PV; Stobie A; Wakenhut F; Whitlock GA
Bioorg Med Chem Lett; 2006 Aug; 16(16):4349-53. PubMed ID: 16750363
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and transporter binding properties of bridged piperazine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909).
Zhang Y; Rothman RB; Dersch CM; de Costa BR; Jacobson AE; Rice KC
J Med Chem; 2000 Dec; 43(25):4840-9. PubMed ID: 11123994
[TBL] [Abstract][Full Text] [Related]
10. Histamine H3 Receptor Ligands in the Group of (Homo)piperazine Derivatives.
Szczepanska K; Kuder K; Kiec-Kononowicz K
Curr Med Chem; 2018; 25(14):1609-1626. PubMed ID: 29173145
[TBL] [Abstract][Full Text] [Related]
11. An Overview of Piperazine Scaffold as Promising Nucleus for Different Therapeutic Targets.
Sharma A; Wakode S; Fayaz F; Khasimbi S; Pottoo FH; Kaur A
Curr Pharm Des; 2020; 26(35):4373-4385. PubMed ID: 32303168
[TBL] [Abstract][Full Text] [Related]
12. A modular lead-oriented synthesis of diverse piperazine, 1,4-diazepane and 1,5-diazocane scaffolds.
James T; Maclellan P; Burslem GM; Simpson I; Grant JA; Warriner S; Sridharan V; Nelson A
Org Biomol Chem; 2014 Apr; 12(16):2584-91. PubMed ID: 24614952
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, biological screening and molecular docking studies of novel multifunctional 1,4-di (aryl/heteroaryl) substituted piperazine derivatives as potential antitubercular and antimicrobial agents.
Mekonnen Sanka B; Mamo Tadesse D; Teju Bedada E; Mengesha ET; Babu G N
Bioorg Chem; 2022 Feb; 119():105568. PubMed ID: 34968884
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 1,2,3-triazole incorporated indole-piperazines as potent antitubercular agents: Design, synthesis, in vitro biological evaluation, molecular docking and ADME studies.
Reddyrajula R; Etikyala U; Manga V; Kumar Dalimba U
Bioorg Med Chem; 2024 Jan; 98():117562. PubMed ID: 38184947
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis and bioactivities of novel dihydroartemisinin-piperazine derivatives containing sulfonamide].
Ma C; Li XQ; Xu J; Chen CX
Yao Xue Xue Bao; 2013 Sep; 48(9):1430-5. PubMed ID: 24358777
[TBL] [Abstract][Full Text] [Related]
16. Determination of piperazine salts in pharmaceutical liquids.
PANKRATZ RE
J Pharm Sci; 1961 Feb; 50():175-7. PubMed ID: 13732477
[No Abstract] [Full Text] [Related]
17. Enhanced D1 affinity in a series of piperazine ring substituted 1-piperazino-3-arylindans with potential atypical antipsychotic activity.
Bøgesø KP; Arnt J; Frederiksen K; Hansen HO; Hyttel J; Pedersen H
J Med Chem; 1995 Oct; 38(22):4380-92. PubMed ID: 7473566
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of noroviruses by piperazine derivatives.
Dou D; He G; Mandadapu SR; Aravapalli S; Kim Y; Chang KO; Groutas WC
Bioorg Med Chem Lett; 2012 Jan; 22(1):377-9. PubMed ID: 22119464
[TBL] [Abstract][Full Text] [Related]
19. Building Up a Piperazine Ring from a Primary Amino Group via Catalytic Reductive Cyclization of Dioximes.
Pospelov EV; Sukhorukov AY
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511552
[TBL] [Abstract][Full Text] [Related]
20. [Design, synthesis and bioactivity of aryl piperazine benzo[b][1,4]oxazine derivatives].
Zheng YY; Xie P; Zhang J; Li JQ; Guo L; Yu LP; Zhou B
Yao Xue Xue Bao; 2012 Jun; 47(6):755-63. PubMed ID: 22919723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
